ArticleJournal of translational medicine2025
Generative and integrative modeling for transcriptomics with formalin fixed paraffin embedded material.
Article in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundFormalin-fixed paraffin embedded (FFPE) samples suffer from the degradation of nucleic acids, a problem that becomes particularly acute with samples stored for extended periods. It remains challenging to profile FFPE using high-throughput sequencing technologies including RNA-sequencing, and the resulting FFPE RNA-seq (fRNA-seq) data has a high rate of transcript dropout, a property shared with single cell RNA-seq. Transcript counts also have high variance and are prone to extreme values, together making downstream analyses extremely challenging.
methodsWe introduce the PaRaffin Embedded Formalin-FixEd Cleaning Tool (PREFFECT), a probabilistic framework for the analysis of fRNA-seq data. PREFFECT uses generative models to fit distributions to observed expression counts while adjusting for technical and biological variables. The framework can exploit multiple expression profiles generated from matched tissues for a single sample (e.g., a tumor and morphologically normal tissue) in order to stabilize profiles and impute missing counts. PREFFECT can also leverage sample-sample adjacency networks that assist graph attention mechanisms to identify the most informative correlations in the data.
resultsWe evaluated the distribution of transcript counts across a compendium of fRNA-seq datasets, finding the negative binomial distribution best fits the data with little evidence supporting zero-inflated extensions. We use this knowledge in the design of PREFFECT. We show that PREFFECT can accurately impute missing values from fRNAseq count matrices and adjust for batch effects. The inclusion of sample-sample adjacency networks and multiple tissues were shown to enhance sample clustering.
conclusionsThe vast majority of studies to date contain at most a few hundred profiles, making it challenging to correctly infer good statistical fits for each transcript especially in complex cohorts, given the noisy, incomplete and heterogeneous nature of the data. The integrative and generative approach of PREFFECT provides better and more specific model fits than generic bulk RNA-seq tools, especially when more advanced PREFFECT models provide matched profiles are included in the analysis. The transformed data can be directly used with many well-established tools for downstream analysis tasks, empowering its use in clinical biomarker studies and diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.